By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aperion Biologics 

11969 Starcrest Drive

San Antonio  Texas  78247  U.S.A.
Phone: 210-858-7070 Fax: 210-495-0239


SEARCH JOBS


Industry
Medical Device






Company News
EUSA Pharma Acquires Global Rights To Neuroblastoma Treatment Isqette (Dinutuximab Beta) From Aperion Biologics 10/4/2016 10:46:26 AM
Aperion Biologics Announces The Filing Of An Offering Statement To Raise $20 Million In A Public Offering Under Regulation A -- WR Hambrecht + Co To Act As Sole Underwriter 9/24/2015 10:55:20 AM
Sanofi (SNY), Evotec AG (EVTG.F), Aperion Biologics Strike Collaborative Cancer Treatment Deal Worth $220 Million 8/10/2015 5:57:16 AM
Aperion Biologics Granted CE Mark For Z-Lig ACL Replacement Device 4/22/2014 6:31:17 AM
Aperion Biologics Completes Enrollment in Z-Lig(TM) Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial 3/28/2012 10:26:19 AM
Aperion Biologics Invited to Present at the UBS Global Life Sciences Conference 9/16/2011 10:42:19 AM
Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig(TM) Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial 9/14/2011 6:17:43 AM
//-->